STAT Plus: We have answers to some of biotech’s burning questions for 2019 — and some new issues to watch
STAT takes a closer look at the most closely followed biotech companies, rounding up answers to some of our earlier questions and posing some new ones.
No hay comentarios:
Publicar un comentario